AcelRx Pharmaceuticals, Inc. Price Today
AcelRx Pharmaceuticals, Inc.
ACRX
Healthcare
$16.04M
💰
Market Cap
0.2
💸
Price to Earnings
$6.4
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
0 |
Strong Buy |
0 |
Hold |
3 |
Sell |
1 |
Strong Sell |
2 |
ACRX Price Forecast Target
1.0 👉 4.0 +306%
ACRX EPS Forecast
6.4 👉 -2.0 +-131%
Financials
Profit Margin
2420 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
0.9% - Insiders
10.1% - Institutions
89.0% - Public
Major Fund Holders
-
💰 Rock Springs Capital Management, LP $208,230.0
-
💰 Tang Capital Management, LLC $128,310.0
-
💰 Vanguard Group Inc $103,813.0
-
💰 Values First Advisors, Inc. $135,909.0
-
💰 Millennium Management Llc $61,450.0
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.📮FAQ
Some Frequently Asked Questions.
The AcelRx Pharmaceuticals, Inc. industry is Drug Manufacturers—Specialty & Generic
The AcelRx Pharmaceuticals, Inc. sector is Healthcare
The AcelRx Pharmaceuticals, Inc. forecasted predicted Price to Earnings PE ratio is -0.5
The AcelRx Pharmaceuticals, Inc. Price to Earnings PE ratio is 0.2
The Market Capitalization of AcelRx Pharmaceuticals, Inc. is $16.04M
There are total of 10841816 float shares with 10.1% held by Institutions and 0.9% held by insiders
The MAcelRx Pharmaceuticals, Inc. forecasted Earnings per Share EPS is $-2.0
The AcelRx Pharmaceuticals, Inc. Earnings per Share EPS is 6.4
The AcelRx Pharmaceuticals, Inc. company has $0 gross profits with 2420 profit margins
The AcelRx Pharmaceuticals, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The AcelRx Pharmaceuticals, Inc. Revenue is $1771000 with 0 revenue growth
The price target for AcelRx Pharmaceuticals, Inc. stock is $4.0 for the high target and $4.0 for the low target
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Hold, with the following breakdown:
- Buy: 0
- Strong Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 2
The Beta of AcelRx Pharmaceuticals, Inc. is 0.3
The dividend of AcelRx Pharmaceuticals, Inc. is $0
The dividend yield of AcelRx Pharmaceuticals, Inc. is 0%
The biggest institutional and mutual fund holders of AcelRx Pharmaceuticals, Inc. stock are
- Rock Springs Capital Management, LP
- Tang Capital Management, LLC
- Vanguard Group Inc
- Values First Advisors, Inc.
The AcelRx Pharmaceuticals, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0